LANGUAGE:
LANGUAGE:
Our people are our pride, helping companies resonate with their customers for 20+ years.
We create, transform, test, and train more content than anyone in the world – from text, voice, audio, video, to structured & unstructured data.
Solutions
Our experts know the in-and-outs of your industry & its challenges.
Harness the Lionbridge Lainguage Cloud to support your end-to-end localization and content lifecycle
Our people are our pride, helping companies resonate with their customers for 20+ years.
About Us
Key Facts
Leadership
Insights
News
Trust Center
We create, transform, test, and train more content than anyone in the world – from text, voice, audio, video, to structured & unstructured data.
Content Services
Technical Writing
Training & eLearning
Financial Reports
Multicultural Marketing
Digital Experience Assessments
Translation Services
Translation
Video Localization
Software Localization
Website Localization
Translation for Regulated Companies
Interpretation
Multilingual SEO & Digital Marketing
Content Optimization
Testing Services
Functional QA & Testing
Compatibility Testing
Interoperability Testing
Performance Testing
Accessibility Testing
UX/CX Testing
Solutions
Digital Marketing
Live Events
Machine Translation
Our Knowledge Hubs
Positive Patient Outcomes
Future of Localization
Innovation to Immunity
COVID-19 Resource Center
Disruption Series
Patient Engagement
Lionbridge Insights
Our experts know the in-and-outs of your industry & its challenges.
Life Sciences
Banking & Finance
Retail
E-Commerce
Games
Automotive
Consumer Packaged Goods
Technology
Industrial Manufacturing
Legal Services
Travel & Hospitality
Harness the Lionbridge Lainguage Cloud to support your end-to-end localization and content lifecycle
Lainguage Cloud™ Platform
Connectivity
Translation Community
Workflow Technology
Smairt Content™
Smairt MT™
Smairt Data™
Language Quality
Analytics
SELECT LANGUAGE:
It’s easy to get lost in questions concerning the future of AI in clinical trials. How should we be using it? How could it change the healthcare industry? But plenty of applications are already live in the R&D process. Contract research organizations and pharmaceutical companies alike have gone on an AI buying frenzy for years. The birth of AI startups seems to outpace even those acquisitions, with new advances emerging regularly.
The truth is: AI isn’t just coming to disrupt healthcare; it’s already here. Here are some places AI is already stepping into the clinical trial equation.
The Internet provides access to virtually endless knowledge. All that information at your fingertips can be both a blessing and a curse—it means many more needles exist in a nearly infinite haystack.
In response to information overload, several healthcare companies have developed versions of AI “study buddies” to help sort through the data. Some of these systems, like the ones from H1 Insights, help with background research.
H1 products examine broad swathes of research divided by therapeutic area, product, or even researcher or thought leader to aggregate useful information. Other companies leverage data mining tools to help predict the likelihood that a patient will have an illness or complication. This is helpful for both preventative medicine and patient stratification for clinical trials.
Global connectivity has greatly expanded the potential patient base for research studies and clinical trials. With AI-powered screening tools, researchers and medical professionals can select more ideally-suited individuals for their studies. Stratifying patients and matching patients with doctors and studies is one of the more prominent areas in which AI supports clinical trials.
For example, through its cancer-focused solution, Belong.life provides a series of personalized benefits for cancer patients. It:
Likewise, TrialJectory also matches cancer patients with potential clinical trials, using self-reported medical data. MassiveBio, another cancer-focused AI business, matches patients and clinical trials. It also helps enterprises seeking more patient data.
These are just a few of the many companies that are leveraging AI tools to help support clinical trial matching. Tools like these help everyone: they make the clinical trial process more effective and efficient, help patients receive the right care, and create more specialized, high-quality datasets that can fuel further research.
One company is taking the optimization trend to the clinical trial world. Medable has designed a suite of tools specifically for the clinical trial workflow. These tools help smooth insight-sharing to eliminate data siloes.
In some ways, any operations-focused AI-powered SaaS platform could provide support for clinical trials. Spreadsheet management, site visitor interactions, and similar tools that users can leverage in any industry can find particular resonance in the clinical trial world. Basic productivity tools can benefit operations across medical and scientific fields.
In short: the clinical trial sphere is ripe for AI disruption, across myriad use cases.
At the molecular level, AI can even help propose and test molecules to defend against certain illnesses. Cloud Pharmaceuticals uses cloud based computing to help propose new drug candidates and has already moved some candidates to pre-clinical stages. BioXcel focuses on neurological and immuno-oncological medicines and works similarly, using AI to propose and model ideas. Atomwise focuses on pediatric patients and can virtually test drugs to predict their success in trials.
Each of these advances could have incredibly positive effects for patients.
From start to finish, and at most steps along the way, AI has the power to push clinical trials into overdrive.
The CROs and pharma companies that embrace AI will continue to lead their industries. Read more about the potential AI holds for CROs here.